Marta Libura
Warsaw, MZ 02091, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.
Journal: Scientific reports
Published: March 02, 2020
Successful Use of Nilotinib in the Therapy of a Patient with a Chemoresistant Relapse of BCR-ABL1-Like Phenotype Acute Lymphoblastic Leukemia.
Journal: Oncology research and treatment
Published: March 02, 2018
CEBPA copy number variations in normal karyotype acute myeloid leukemia: Possible role of breakpoint-associated microhomology and chromatin status in CEBPA mutagenesis.
Journal: Blood cells, molecules & diseases
Published: January 24, 2015
Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Journal: Molecular medicine reports
Published: February 14, 2014
Comparison of promoter DNA methylation and expression levels of genes encoding CCAAT/enhancer binding proteins in AML patients.
Journal: Leukemia research
Published: December 17, 2013
Repetitive genomic elements and overall DNA methylation changes in acute myeloid and childhood B-cell lymphoblastic leukemia patients.
Journal: International journal of hematology
Published: July 22, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026